journal
https://read.qxmd.com/read/38660819/discriminative-stimulus-properties-of-cannabis-sativa-terpenes-in-rats
#1
JOURNAL ARTICLE
Lawrence M Carey, Saba Ghodrati, Charles P France
Cannabis is a pharmacologically complex plant consisting of hundreds of potentially active compounds. One class of compounds present in cannabis that has received little attention are terpenes. Traditionally thought to impart aroma and flavor to cannabis, it has become increasingly recognized that terpenes might exert therapeutic effects themselves. Several recent reports have also indicated terpenes might behave as cannabinoid type 1 (CB1) receptor agonists. This study aimed to investigate whether several terpenes present in cannabis produce discriminative stimulus effects similar to or enhance the effects of Δ9-tetrahydrocannabinol (THC)...
April 25, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38660812/thymoquinone-ameliorates-symptoms-of-parkinson-s-disease-in-a-6-ohda-rat-model-by-downregulation-of-mir-204-3p
#2
JOURNAL ARTICLE
Mukaddes Pala, Ismail Meral, Nilgün Pala Acikgoz, Murat Mengi, Meryem Betül Erdim Gokce, Rumeysa Unsal, Yalcin Polat, Fahri Akbas, Senay Gorucu Yilmaz
microRNAs (miRNAs) play a significant role in the pathophysiology of Parkinson's disease. In this study, we evaluated the neuroprotective effect of thymoquinone on the expression profiles of miRNA and cognitive functions in the 6-hydroxydopamine (6-OHDA)-induced Parkinson's model. Male adult Wistar albino rats (200-230 g, n = 36) were randomly assigned to six groups: Sham, thymoquinone (10 mg/kg, p.o.), 6-OHDA, 6-OHDA + thymoquinone (10 mg/kg), 6-OHDA + thymoquinone (20 mg/kg), and 6-OHDA + thymoquinone (50 mg/kg)...
April 25, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651984/immunization-with-a-low-dose-of-zymosan-a-confers-resistance-to-depression-like-behavior-and-neuroinflammatory-responses-in-chronically-stressed-mice
#3
JOURNAL ARTICLE
Huijun Liu, Tao Zhu, Linlin Zhang, Fu Li, Meng Zheng, Bingran Chen, Haojie Zhu, Jie Ren, Xu Lu, Chao Huang
Stimulation of the innate immune system prior to stress exposure is a possible strategy to prevent depression under stressful conditions. Based on the innate immune system stimulating activities of zymosan A, we hypothesize that zymosan A may prevent the development of chronic stress-induced depression-like behavior. Our results showed that a single injection of zymosan A 1 day before stress exposure at a dose of 2 or 4 mg/kg, but not at a dose of 1 mg/kg, prevented the development of depression-like behaviors in mice treated with chronic social defeat stress (CSDS)...
April 24, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651981/nsc689857-an-inhibitor-of-skp2-produces-antidepressant-like-effects-in-mice
#4
JOURNAL ARTICLE
Qingqing Liu, Li Cheng, Fu Li, Haojie Zhu, Xu Lu, Chao Huang, Xiaomei Yuan
We have previously reported that two inhibitors of an E3 ligase S-phase kinase-associated protein 2 (Skp2), SMIP004 and C1, have an antidepressant-like effect in non-stressed and chronically stressed mice. This prompted us to ask whether other Skp2 inhibitors could also have an antidepressant effect. Here, we used NSC689857, another Skp2 inhibitor, to investigate this hypothesis. The results showed that administration of NSC689857 (5 mg/kg) produced an antidepressant-like effect in a time-dependent manner in non-stressed male mice, which started 8 days after drug administration...
April 24, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651979/prior-cocaine-self-administration-does-not-impair-the-ability-to-delay-gratification-in-rats-during-diminishing-returns
#5
JOURNAL ARTICLE
H J Pribut, N Kang, Matthew R Roesch
Previous exposure to drugs of abuse produces impairments in studies of reversal learning, delay discounting and response inhibition tasks. While these studies contribute to the understanding of normal decision-making and how it is impaired by drugs of abuse, they do not fully capture how decision-making impacts the ability to delay gratification for greater long-term benefit. To address this issue, we used a diminishing returns task to study decision-making in rats that had previously self-administered cocaine...
April 24, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651975/chronic-caffeine-decreases-anxiety-like-behavior-in-the-marble-burying-task-in-adolescent-rats
#6
JOURNAL ARTICLE
Gwi Park, Sarah M Turgeon
Exposure to chronic caffeine during adolescence has been shown to produce decreased anxiety-like behaviors in rats as well as decreased immobility in the forced swim test (FST) suggesting an antidepressant-like effect. The effects of chronic caffeine on anxiety, however, have been found to be test-dependent and sexually dimorphic. In addition, decreased immobility in the FST has been argued to reflect a shift toward active coping behavior as opposed to an antidepressant-like effect. In order to further characterize the effects of adolescent caffeine exposure, the present experiment assessed the effects of caffeine on marble burying behavior in a two-zone marble burying task...
April 24, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651685/is-impulsivity-related-to-attentional-bias-in-cigarette-smokers-an-exploration-across-levels-of-nicotine-dependency-and-deprivation
#7
JOURNAL ARTICLE
Katerina Z Kolokotroni, Therese E Fozard, Danielle L Selby, Amanda A Harrison
Research has largely focused on how attentional bias to smoking-related cues and impulsivity independently influence the development and maintenance of cigarette smoking, with limited exploration of the relationship between these mechanisms. The current experiments systematically assessed relationships between multiple dimensions of impulsivity and attentional bias, at different stages of attention, in smokers varying in nicotine dependency and deprivation. Nonsmokers (NS; n = 26), light-satiated smokers (LS; n = 25), heavy-satiated smokers (HS; n = 23) and heavy 12-hour nicotine-deprived smokers (HD; n = 30) completed the Barratt Impulsivity Scale, delayed discounting task, stop-signal task, information sampling task and a visual dot-probe assessing initial orientation (200 ms) and sustained attention (2000 ms) toward smoking-related cues...
April 22, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38567447/crocin-bioactive-compound-of-crocus-sativus-l-potently-restores-rem-sleep-deprivation-induced-manic-and-obsessive-compulsive-like-behaviors-in-female-rats
#8
JOURNAL ARTICLE
Mohammad Houshyar, Hanie Karimi, Zahra Ghofrani-Jahromi, Sarah Nouri, Salar Vaseghi
Rapid-eye movement (REM) sleep deprivation (SD) can induce manic-like behaviors including hyperlocomotion. On the other hand, crocin (one of the main compounds of Crocus sativus L. or Saffron) may be beneficial in the improvement of mental and cognitive dysfunctions. Also, crocin can restore the deleterious effects of SD on mental and cognitive processes. In this study, we investigated the effect of REM SD on female rats' behaviors including depression- and anxiety-like behaviors, locomotion, pain perception, and obsessive-compulsive-like behavior, and also, the potential effect of crocin on REM SD effects...
March 29, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38567425/skf82958-a-dopamine-d1-receptor-agonist-disrupts-prepulse-inhibition-in-the-medial-prefrontal-cortex-and-nucleus-accumbens-in-c57bl-6j-mice
#9
JOURNAL ARTICLE
Chengmei Yang, Xiaoyu Chen, Jingyang Xu, Weihai Chen
Prepulse inhibition (PPI) is a crucial indicator of sensorimotor gating that is often impaired in neuropsychiatric diseases. Although dopamine D1 receptor agonists have been found to disrupt PPI in mice, the underlying mechanisms are not fully understood. In this study, we aimed to identify the brain regions responsible for the PPI-disruptive effect of the D1 agonist in mice. Results demonstrated that intraperitoneal administration of the selective dopamine D1 receptor agonist SKF82958 dramatically inhibited PPI, while the dopamine D1 receptor antagonist SCH23390 enhanced PPI...
March 29, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38563661/activation-of-mglu2-3-receptors-with-the-orthosteric-agonist-ly-404-039-alleviates-dyskinesia-in-experimental-parkinsonism
#10
JOURNAL ARTICLE
Woojin Kang, Imane Frouni, Cynthia Kwan, Louis Desbiens, Adjia Hamadjida, Philippe Huot
LY-404,039 is an orthosteric agonist at metabotropic glutamate 2 and 3 (mGlu2/3) receptors, with a possible additional agonist effect at dopamine D2 receptors. LY-404,039 and its pro-drug, LY-2140023, have previously been tested in clinical trials for psychiatric indications and could therefore be repurposed if they were shown to be efficacious in other conditions. We have recently demonstrated that the mGlu2/3 orthosteric agonist LY-354,740 alleviated L-3,4-dihydroxyphenylalanine (L-DOPA)-induced abnormal involuntary movements (AIMs) in the 6-hydroxydopamine (6-OHDA)-lesioned rat without hampering the anti-parkinsonian action of L-DOPA...
March 29, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38451025/neuronal-nicotinic-acetylcholine-receptor-of-the-central-amygdala-modulates-the-ethanol-induced-tolerance-to-anxiolysis-and-withdrawal-induced-anxiety-in-male-rats
#11
JOURNAL ARTICLE
Antariksha Duratkar, Richa Patel, Nishant Sudhir Jain
The nicotine acetylcholinergic receptor (nAchR) in the central nucleus of the amygdala (CeA) is known to modulate anxiety traits as well as ethanol-induced behavioral effects. Therefore, the present study investigated the role of CeA nAChR in the tolerance to ethanol anxiolysis and withdrawal-induced anxiety-related effects in rats on elevated plus maze (EPM). To develop ethanol dependence, rats were given free access to an ethanol-containing liquid diet for 10 days. To assess the development of tolerance, separate groups of rats were challenged with ethanol (2 g/kg, i...
April 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38451024/antinociceptive-and-adverse-effects-of-morphine-ketamine-mixtures-in-rats
#12
JOURNAL ARTICLE
Conor D Strumberger, Evangeline J D'Epagnier, Kevin H Nguyen, John D Rogers, Matthew P Meyer, Yashmita Malhotra, Jillian E Hinman, Elisabeth L Jansen, Vanessa Minervini
Prescription opioids are the gold standard for treating moderate to severe pain despite their well-documented adverse effects. Of all prescription medications, opioids are abused most widely, and fatal overdoses have reached epidemic levels. One strategy for improving the margin of safety of opioids is combining them with non-opioid drugs to decrease the opioid dose needed for pain relief, thereby reducing adverse effects that occur with larger doses. The N-methyl-D-aspartate receptor antagonist ketamine has been used safely as an analgesic but only under a very limited range of conditions...
April 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38451023/opioid-receptor-antagonists-reduce-motivated-wheel-running-behavior-in-mice
#13
JOURNAL ARTICLE
Nobue Kitanaka, Kanayo Arai, Kaoko Takehara, F Scott Hall, Kazuo Tomita, Kento Igarashi, Tomoaki Sato, George R Uhl, Junichi Kitanaka
We hypothesized that opioid receptor antagonists would inhibit motivated behavior produced by a natural reward. To evaluate motivated responses to a natural reward, mice were given access to running wheels for 71.5 h in a multi-configuration testing apparatus. In addition to a running wheel activity, locomotor activity (outside of the wheel), food and water intake, and access to a food container were measured in the apparatus. Mice were also tested separately for novel-object exploration to investigate whether naloxone affects behavior unrelated to natural reward...
April 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38451022/positive-modulation-of-%C3%AE-amino-3-hydroxy-5-methyl-4-isoxazolepropionic-acid-receptors-differentially-alters-spatial-learning-and-memory-in-juvenile-rats-younger-and-older-than-three-weeks
#14
JOURNAL ARTICLE
Nicholas R Mill, Richard H Ogoe, Nazanin Valibeigi, Diyi Chen, Carmen L Kimbal, Stanley J Yoon, Shaunak Ganju, Josue A Perdomo, Anjali Sardana, Daniel G McHail, Diego A Gonzalez, Theodore C Dumas
Remarkable performance improvements occur at the end of the third postnatal week in rodents tested in various tasks that require navigation according to spatial context. While alterations in hippocampal function at least partially subserve this cognitive advancement, physiological explanations remain incomplete. Previously, we discovered that developmental modifications to hippocampal glutamatergic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in juvenile rats was related to more mature spontaneous alternation behavior in a symmetrical Y-maze...
April 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38375659/examination-of-the-mechanisms-underlying-the-discriminative-stimulus-properties-of-the-atypical-antipsychotic-amisulpride
#15
JOURNAL ARTICLE
Timothy J Donahue, Todd M Hillhouse, Kevin A Webster, Richard Young, Eliseu O De Oliveira, Joseph H Porter
Amisulpride is an atypical benzamide antipsychotic/antidepressant, whose mechanism of action is thought to depend mainly on dopamine D2/3 receptor activity, but also with some serotonin 5-HT2B/7 effects. The present study examined the role of D2/3 receptors and 5-HT2B/7 receptors in amisulpride's discriminative stimulus. Selective agonists and antagonists of the above receptors were tested in adult, male C57BL/6 mice trained to discriminate 10 mg/kg amisulpride from vehicle in a two-lever drug discrimination assay...
February 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38375658/minocycline-as-a-potential-anxiolytic-drug-systematic-review-and-meta-analysis-of-evidence-in-murine-models
#16
JOURNAL ARTICLE
Lia P Iglesias, Nicia Soares, Laila Asth, Fabricio A Moreira, Daniele C Aguiar
Minocycline is a tetracycline antibiotic with off-label use as an anti-inflammatory drug. Because it can cross the blood-brain barrier, minocycline has been proposed as an alternative treatment for psychiatric disorders, in which inflammation plays an important role. However, its beneficial effects on anxiety disorders are unclear. Therefore, we performed a systematic review and meta-analysis to evaluate the efficacy of minocycline as an anxiolytic drug in preclinical models. We performed a PubMed search according to the PRISMA guidelines and PICOS strategy...
February 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38375657/announcement-of-new-editor-bart-ellenbroek
#17
JOURNAL ARTICLE
Louk Vanderschuren
No abstract text is available yet for this article.
February 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38375656/paul-willner-obituary
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 1, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38085665/discriminative-stimulus-effects-of-cannabidiol-oil-in-sprague-dawley-rats
#19
JOURNAL ARTICLE
Rebecca L Chalmé, Michelle A Frankot, Karen G Anderson
Cannabidiol (CBD) is one of the major centrally active phytocannabinoid components of cannabis, and has been approved by the FDA only for the treatment of seizures associated with three rare disorders. It has also been touted as a potential treatment for anxiety in place of more traditional treatments like benzodiazepines. Although there is some evidence of anxiolytic effects of CBD, its suitability as a substitute for benzodiazepines is unknown. This experiment was designed to assess the extent to which CBD shares interoceptive discriminative-stimulus properties with the anxiolytic drug chlordiazepoxide (CDP), a benzodiazepine...
December 13, 2023: Behavioural Pharmacology
https://read.qxmd.com/read/38085651/cb2-agonist-mitigates-cocaine-induced-reinstatement-of-place-preference-and-modulates-the-inflammatory-response-in-mice
#20
JOURNAL ARTICLE
Oualid Abboussi, Zmarak Ahmad Khan, Hind Ibork, Simo S Zulu, William Daniels, Khalid Taghzouti, Tim G Hales
Chronic exposure to cocaine is known to have profound effects on the brain, leading to the dysregulation of inflammatory signalling pathways, the activation of microglia, and the manifestation of cognitive and motivational behavioural impairments. The endocannabinoid system has emerged as a potential mediator of cocaine's deleterious effects. In this study, we sought to investigate the therapeutic potential of the cannabinoid CB2 receptor agonist, JWH-133, in mitigating cocaine-induced inflammation and associated motivational behavioural alterations in an in vivo model...
December 13, 2023: Behavioural Pharmacology
journal
journal
30543
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.